For: | Höpfner M, Schuppan D, Scherübl H. Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: Recent advances and future perspectives. World J Gastroenterol 2008; 14(16): 2461-2473 [PMID: 18442192 DOI: 10.3748/wjg.14.2461] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i16/2461.htm |
Number | Citing Articles |
1 |
Nicola Fazio, Saverio Cinieri, Katia Lorizzo, Michela Squadroni, Laura Orlando, Francesca Spada, Evaristo Maiello, Lisa Bodei, Giovanni Paganelli, Gianfranco Delle Fave, Filippo de Braud. Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas. Cancer Treatment Reviews 2010; 36: S87 doi: 10.1016/S0305-7372(10)70026-8
|
2 |
Alessia Di Florio, Veronica Sancho, Paola Moreno, Gianfranco Delle Fave, Robert T. Jensen. Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013; 1833(3): 573 doi: 10.1016/j.bbamcr.2012.11.021
|
3 |
Sashikanta Swain, Ravi Kant Narayan, Pravash Ranjan Mishra. Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesis. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1461278
|
4 |
Conor J. Shields, Emmanuel Tiret, Desmond C. Winter. Carcinoid Tumors of the Rectum. Annals of Surgery 2010; 252(5): 750 doi: 10.1097/SLA.0b013e3181fb8df6
|
5 |
Katsunobu SAKURAI, Tadashi TSUKAMOTO, Sadatoshi SHIMIZU, Akishige KANAZAWA, Yoshito YAMASHITA, Yukio NISHIGUCHI. A CASE OF NEUROENDOCRINE CARCINOMA ORIGINATING FROM THE PAPILLA VATER OF THE DUODENUM. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2010; 71(3): 712 doi: 10.3919/jjsa.71.712
|
6 |
Giovanni Vitale, Silvia Carra, Francesco Ferraù, Elia Guadagno, Antongiulio Faggiano, Annamaria Colao. Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications. Critical Reviews in Oncology/Hematology 2020; 146: 102840 doi: 10.1016/j.critrevonc.2019.102840
|
7 |
Simona Falletta, Stefano Partelli, Corrado Rubini, Dominik Nann, Andrea Doria, Ilaria Marinoni, Vanessa Polenta, Carmelina Di Pasquale, Ettore degli Uberti, Aurel Perren, Massimo Falconi, Maria Chiara Zatelli. mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors. Endocrine-Related Cancer 2016; 23(11): 883 doi: 10.1530/ERC-16-0329
|
8 |
Christophe Couderc, Gilles Poncet, Karine Villaume, Martine Blanc, Nicolas Gadot, Thomas Walter, Florian Lepinasse, Valérie Hervieu, Martine Cordier-Bussat, Jean-Yves Scoazec, Colette Roche. Targeting the PI3K/mTOR Pathway in Murine Endocrine Cell Lines. The American Journal of Pathology 2011; 178(1): 336 doi: 10.1016/j.ajpath.2010.11.023
|
9 |
Nupur K. Purohit, Rashmi G. Shah, Samuel Adant, Michael Hoepfner, Girish M. Shah, Jean-Mathieu Beauregard. Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor. Oncotarget 2018; 9(37): 24693 doi: 10.18632/oncotarget.25266
|
10 |
Elizabeth Batcher, Paul Madaj, Andrew G. Gianoukakis. Pancreatic Neuroendocrine Tumors. Endocrine Research 2011; 36(1): 35 doi: 10.3109/07435800.2010.525085
|
11 |
Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 2009; 16(4): 328 doi: 10.1097/MED.0b013e32832eb365
|
12 |
Emilio Bajetta, Giuseppe Procopio, Sara Pusceddu, Filippo Pietrantonio, Massimo Milione, Marco Maccauro, Elena Verzoni, Valentina Guadalupi, Marco Platania. From biology to clinical experience: evolution in the knowledge of neuroendocrine tumours. Oncology Reviews 2009; 3(2): 79 doi: 10.1007/s12156-009-0011-x
|
13 |
Hisato IGARASHI, Ken KAWABE, Tetsuhide ITO. Diagnosis and medical management of pancreatic endocrine tumor: Insulinoma. Suizo 2008; 23(6): 676 doi: 10.2958/suizo.23.676
|
14 |
Verena Schenk, Elisabeth Rossegger, Clemens Ebner, Florian Bangerl, Klaus Reichmann, Björn Hoffmann, Michael Höpfner, Frank Wiesbrock. RGD-Functionalization of Poly(2-oxazoline)-Based Networks for Enhanced Adhesion to Cancer Cells. Polymers 2014; 6(2): 264 doi: 10.3390/polym6020264
|
15 |
Michelle Kang Kim, Fei Ye, Daguang Wang, Miao Cui, Stephen C. Ward, Richard R.P. Warner, Sasan Roayaie, Michail Shafir, Myron Schwartz, David Zhang, Steven Itzkowitz. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases. Pancreas 2016; 45(4): 528 doi: 10.1097/MPA.0000000000000459
|